Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent
1998-09-24
2000-08-29
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
514153, A61K 3165
Patent
active
061109053
ABSTRACT:
An injectable composition of higher residual effect with reduced detrimental effects such as pain at injection site, swelling, tissue irritancy or necrosis and containing as active principle a tetracycline compound, either as the free base or a salt thereof with a physiologically acceptable acid, complexed with a substantially equimolar amount of a magnesium compound, is solubilized in a water miscible solvent system comprising, either (i) a) glycerol formal in an amount of from about 10 to 50% v/v; with b) polyethylene glycol in an amount of from about 1 to 15% v/v; or (ii) from about 25 to about 75% v/v of N-methylpyrrolidone, the composition optionally containing a pH modifier in an amount sufficient to maintain a physiochemically acceptable pH, the balance being made up with water q.s.
REFERENCES:
patent: 4772460 (1988-09-01), Malook et al.
patent: 5075295 (1991-12-01), Zupan et al.
Holmes Drew
Patterson Alan
Goldberg Jerome D.
Norbrook Laboratories Limited
Shannon John P.
LandOfFree
Long-acting oxytetracycline composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long-acting oxytetracycline composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long-acting oxytetracycline composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1250010